Pediatrics Doctors in Bartlesville, OK Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Dr. Paul Wilson Mcquillen Jr., M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3400 E Frank Phillips Blvd, Suite302, Bartlesville, OK 74006 Phone: 918-331-2468    Fax: 918-331-2469

Helen M Bumpus, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3450 E Frank Phillips, Suite 100, Bartlesville, OK 74006 Phone: 918-338-3777    Fax: 918-331-2346

Dr. Linda Woolbright Doyle, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3400 E Frank Phillips Blvd, Suite302, Bartlesville, OK 74006 Phone: 918-331-2468    Fax: 918-331-2469

Dr. Gopal Chandrasekharan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3400 E Frank Phillips Blvd Ste 302, Bartlesville, OK 74006 Phone: 918-331-2468    Fax: 918-331-2469

News Archive

PHT signs 11 new trials in second-quarter 2010

PHT Corporation featured scientific education as a key focus during its record-breaking second fiscal quarter of 2010. PHT is the global innovator in ePRO (electronic patient reported outcome) and PRO (patient reported outcome) solutions that maximize clinical data management by incorporating the world's best digital diaries in eClinical trials.

Framework Convention on Tobacco Control (WHO FCTC) entered into force today

The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) entered into force today. This represents an historical moment in public health, as the Treaty gives countries more tools to control tobacco use and save lives.

Sales of Merck's telcagepant and CoLucid's lasmiditan in world's major markets to reach $1.3 billion in 2019

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that two first-in-class agents — Merck's telcagepant and CoLucid's lasmiditan — will earn combined sales of approximately $1.3 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.

Circumcision shown not to reduce sexual satisfaction and performance

More than 98 per cent of men who are circumcised can enjoy the same levels of sexual satisfaction and performance as men who are not, according to a study of nearly 4,500 males published in the January issue of the UK-based urology journal BJU International.

FDA approves Xeloda (capecitabine) oral chemotherapy

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xeloda (capecitabine) - an innovative oral chemotherapy - for the adjuvant (post-surgery) treatment of patients with Dukes' C colon cancer.

Read more Medical News

› Verified 9 days ago